H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.2% of adults in Surprise have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Census population 152,004. Arizona Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Surprise clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Surprise storefront.
Wharton's Jelly Allograft Products in Surprise, AZ for clinics & physicians. Wharton's jelly allografts ri… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 28% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.2% of adults in Surprise have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. whartons jelly allograft inventory is national; utilization is JF-local.
National Wharton's Jelly Allograft Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Surprise we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.2% of adults in Surprise have diagnosed diabetes — 0.8 points below the U.S. 12% figure.
We are not going to invent a Surprise warehouse or a five-star local review. What you get is whartons jelly allograft from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.2% of adults — 0.8 points below the U.S. 12% figure. Obesity is 29.4%; arthritis is 28%. That is place-level BRFSS modeling, not a clinic census and not a Surprise trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JF reviewers and surveyors expect — not a brochure.
Arizona is JF. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Arizona compliance risk.
If you operate in Arizona and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Surprise tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Surprise, AZ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Surprise is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Surprise — 0.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Arizona Part B wound biologics follow this contractor (siblings: AK, ID, MT, ND, OR, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Surprise. Useful for joint-program math; still needs a diagnosis and privileging.
No Surprise storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.